---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-26-002140"
form_type: "8-K"
ticker: "ASPI"
cik: "0001921865"
company_name: "ASP Isotopes Inc."
filed_at: "2026-04-13T23:59:59+00:00"
generated_at: "2026-05-15T06:37:21.459379+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# ASP Isotopes targets first commercial shipments in 2026 and >$300M EBITDA by 2031

## Summary
- First commercial shipments of Silicon-28, Carbon-14, and Ytterbium-176 expected in Q2–Q3 2026.
- Helium Phase 1 nameplate capacity of 58 MCF/day liquid helium expected by Q3 2026.
- Cash, equivalents, and marketable securities totaled $333M as of Dec 31, 2025.
- Acquired two U.S. radiopharmacies (Florida Oct 2025, South Carolina) for radiopharmaceutical expansion.
- QLE submitted draft S-1 for public listing and signed MOU with large U.S. energy company for enriched uranium.

## SEC filing metadata
- accession: 0001477932-26-002140
- form_type: 8-K
- ticker: ASPI
- cik: 0001921865
- company_name: ASP Isotopes Inc.
- filed_at: 2026-04-13T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1921865/000147793226002140/0001477932-26-002140-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1921865/000147793226002140/aspi_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-26-002140
- JSON: https://secwatch.observer/filing/0001477932-26-002140.json
- Plain text: https://secwatch.observer/filing/0001477932-26-002140.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.